卓明磊主治醫(yī)師
北京大學(xué)腫瘤醫(yī)院胸部腫瘤內(nèi)一科
卓明磊，主治醫(yī)師，博士學(xué)位。2002年畢業(yè)于中國協(xié)和醫(yī)科大學(xué)，獲臨床醫(yī)學(xué)博士、生化與分子生物學(xué)博士學(xué)位。博士在讀期間，以第一作者身份發(fā)表SCI論文3篇。自2007年8月于北京大學(xué)腫瘤醫(yī)院工作至今，期間，參與多項(xiàng)臨床研究，發(fā)表論文多篇。曾為《中華腫瘤雜志》等雜志審稿，多次為《腫瘤時(shí)訊》、《中國醫(yī)學(xué)論壇報(bào)》撰稿。 專業(yè)特長 基因分型基礎(chǔ)上的肺癌的個(gè)體化、多學(xué)科綜合治療 研究成果 先后獲得教育部科技成果二等獎(jiǎng)、華夏科技成果二等獎(jiǎng)及北京市科技進(jìn)步三等獎(jiǎng)、中華醫(yī)學(xué)獎(jiǎng)三等獎(jiǎng)等獎(jiǎng)勵(lì)。 主要論著 1) Hua Bai, Zhijie Wang, Keneng Chen, Jun Zhao, Shuhang Wang, Qinghua Zhou, Minglei Zhuo, Tongtong An, Jianchun Duan, Lu Yang, Meina Wu, Zhen Liang, Yuyan Wang1, Xiaozheng Kang, Jie Wang. Influence of Chemotherapy on EGFR Mutation Status for Patients with Non-small Cell Lung Cancer. J Clin Oncol，2012 2) Shuhang wang , Tongtong An, Jie Wang, Jun Zhao, Zhijie Wang, Minglei Zhuo, Hua Bai, Lu Yang, Yan Zhang, Xin Wang, Jianchun Duan, Yuyan Wang, Qingzhi Guo, Meina Wu. Potential clinical significance of a plasma-based KRAS mutation analysis in patients with advanced NSCLC. Clin Cancer Res 2010, 15,16(4):1324-1330 3) Zhuo Ming-lei, Wang Jie. Personalized therapy with EGFR-TKI in non-small cell lung cancer: consensus and controversy. Journal of the HONG KONG College of Radiologists. 2010, 13(3), 10-16 4) Zhuo Ming-lei, WU Mei-na, ZHAO Jun, Sonya Wei Song, BAI Hua, WANG Shu-hang, YANG Lu, AN Tong-tong, WANG Xin, DUAN Jian-chun, WANG Yu-yan, GUO Qing-zhi, LIU Xu-yi, LIU Ning-hong, WANG Jie Epidermal growth factor receptor genotype in plasma DNA and outcome of chemotherapy in the Chinese patients with advanced non-small cell lung cancer. Chinese Medical Journal 2011;124(21) :3510-3514 5) Zhijie Wang, Xuchao Zhang, Hua Bai, Jun Zhao, Minglei Zhuo, Tongtong An, Jianchun Duan, Lu Yang, Meina Wu, Shuhang Wang, Yuyan Wang, Yilong Wu and Jie Wang. NSCLC patients with EML4-ALK rearrangement cannot benefit from EGFR-TKI. Oncology, 2012.
胸部腫瘤內(nèi)科問題?
確定要退出登錄嗎？
